CONTEXT AND OBJECTIVE: Cancer patients undergoing bone marrow transplantation (BMT) often require nutritional therapy due to treatment toxicities. The aim here was to evaluate the use of tube feeding and its applicability, indications, contraindications and complications in these patients. DESIGN AND SETTING: Prospective observational study conducted at a public university in São Paulo between January 2002 and August 2007. METHODS: The patients were followed up daily in the BMT unit by a research dietitian. Tube feeding was indicated when oral supplementation proved to be insufficient, when the patient had severe malnutrition or there was an impediment to use of oral feeding. It was contraindicated in the presence of gastrointestinal toxicity of grade 3 and 4 or other conditions that implied a risk or hindered its use or placement.
INTRODUCTION
Bone marrow transplantation (BMT) or hematopoietic stem cell transplantation (HSCT) is a recognized therapeutic method for a variety of hematologic malignancies, congenital abnormalities and malignancies. The procedure is used to restore bone marrow function in patients receiving intensive chemotherapy and radiation, through infusion of progenitor cells or stem cells with an ability to multiply and differentiate into all types of mature blood cells: red cells, white cells and platelets. 1 The transplants may be autologous or allogenic, depending on the origin of the cells. When the cells originate from the patient, the transplant is autologous, but when they are donated by another individual, it is allogenic. If the donor is an identical twin, the transplant is called syngenic. 1, 2 The complications from BMT can be acute or chronic and depend on the underlying disease and its initial condition before the procedure, the type of transplant, the chemotherapy and the preparatory regimen for radiotherapy. The main post-transplant complications include bleeding, infections, organ failure, graft versus host disease (GVHD), graft failure or rejection, and recurrent disease. 2 Besides these complications, nutritional status is strongly affected by the process of BMT. The reduced protein intake, for example, may influence immune function during metabolic stress. Thus, studies have demonstrated the importance of adjusting the energy needs to maintain a zero nitrogen balance. [3] [4] [5] Patients who receive BMT often require nutritional support because of their reduced food intake, which is associated with the toxicities of the conditioning regimen, especially in the gastrointestinal tract. 5, 6 Patients receiving allogenic BMT undergo a conditioning regimen with high-dose chemotherapy combined with total body irradiation, thereby leading to immunosuppression. The body irradiation is extremely toxic and leads to severe and prolonged mucositis. These patients' immunity is more highly compromised and they are at greater risk of overall complications than are those who undergo autologous BMT. Therefore, it is believed that patients who undergo allogenic BMT are also at greater risk of nutritional and metabolic complications and therefore need specialized nutritional support. 7 Total parenteral nutrition (TPN) has been the method most commonly used to provide nutrients during BMT. However, circumstances such as risk of infection and lipid and glucose metabolism disorders may limit its use in these patients.
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OBJECTIVE
Since it is known that patients undergoing BMT often require nutritional support due to treatment toxicities, the objective of the present study was to evaluate the use of enteral nutrition through tube feeding and its applicability, indications, contraindications and complications in patients undergoing BMT, with comparisons between autologous and allogenic transplants.
METHODS
This was a prospective observational study carried out from January 2002 to August 2007, among patients admitted to undergo autologous or allogenic BMT procedures. The study was conducted in accordance with a follow-up protocol from the BMT research unit at a pediatric oncology institute in a public university in São Paulo.
The study included all patients diagnosed with cancer for whom BMT was indicated, and the study excluded those whose family or legal guardian (and the patient, if over 18 years) had not agreed to sign the consent form, thereby refusing to participate.
Patients who had been referred for transplantation but were not suffering from cancer were also excluded.
The patients were followed up daily by a research dietitian, using a standardized report form schedule that had been developed to gather data on food intake; gastrointestinal signs and symptoms; oral supplements; administration of and indi- Weight-for-height (W/H) Z-scores from < -1.0 to -2.0 among children 12 and body mass index (BMI) from greater than or equal to the fifth percentile to greater than the fifteenth percentile among adolescents 13 were considered to represent mild malnutrition; and W/H Z-scores < -2.0 in children and less than the fifth percentile of BMI in adolescents were considered severe. 14 In young adults, the WHO cutoff values 15 were applied: < 18.5 for mild and < 17 for severe malnutrition.
Nutritional management
Indications for nutritional support were made in accordance with the routine protocol of the transplantation unit. They were applied by the nutrition team and consisted of indications of nutritional supplementation when the food intake was insufficient (less than 70-80% of energy needs) for three to five days. 
Statistical analysis
The data were registered and analyzed using the NCSS/PASS statistical software. 17 Differences between groups were investigated using the Mann-Whitney test for continuous variables. For categorical variables, the chi-square test was applied.
The sample size was calculated considering an estimated rate of 30% for the malnutrition outcome in the autologous group and 60% in the allogenic group, a significance level of 5% (chance of type 1 error or alpha = 0.05) and a power of 80% (chance of type 2 error or beta = 0.2).
Ethics committee
The nutritional support protocol from which this analysis was derived was approved by the Institutional Review Board/Ethics Committee of Universidade Federal de São Paulo -Escola Paulista de Medicina (Unifesp-EPM), under protocol number 0132/06. Informed consent was obtained from the parents, guardians or patients, after the study protocol had been explained to them.
RESULTS
Eighty-nine patients out of the 101 followed up during the study period fulfilled the inclusion criteria: 45 autologous transplant cases (50.6%) and 44 allogenic transplant cases (49.5%). Of these, forty-two (47.2%) had an indication for tube feeding: 18 autologous and 24 allogenic cases ( Table 1) . The patients' demographic characteristics are shown in Table 2 .
The mean of length of hospital stay was 30.4 days for autologous and 37.2 days for allogenic transplant patients (P = 0.06). Among the patients who underwent autologous transplantation, the main reasons for the tube indication were inadequate oral food and supplement intake in eleven (61%), insufficient supplement and food intake with malnutrition or weight loss in five (28%) and severe malnutrition in two (11%). Among the patients who underwent allogenic BMT, the reasons were: inadequate oral food and supplement intake in 17 (70.8%), insufficient oral food and supplement intake with malnutrition or weight loss in four (16.7%) and need for oral fasting in three (12.5%). Comparing the autologous and allogenic groups, there was no difference in the numbers of patients with inadequate food intake or with malnutrition and weight loss. Table 3 shows the nutritional status of the group.
In the light of these indications, 31 (73.8%) received tube feeding and 11 (26.2%) did not. Out of the 31 patients with the tube, 11 were autologous and 20 were allogenic cases (P = 0.04).
Among the autologous cases, the reasons associated with not using tube feeding were non-acceptance by the patient or fam- and problems with the tube (tube clogging) in two (6.5%).
Comparing the complications between the autologous and allogenic cases (36% versus 60%; not significant), intensification Table 3 . Nutritional diagnosis of the patients before bone marrow transplant (at admission) and afterwards (at discharge) (n = 31) * * Four patients were lost at discharge: one autologous case with normal weight at admission and three allogenic cases (one obese individual and two with normal weight at admission).
of the episodes of vomiting or diarrhea was found in one (9.1%) versus four (20%), respectively. The three patients with fungal infection in the oral cavity belonged to the allogenic group. Tube clogging and tube dislodgement were found in 9% versus 5% and 18.2% versus 20% in the autologous and allogenic cases, respectively (not significant). 
DISCUSSION
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Therefore, nutritional therapy has been widely recommended for pediatric patients undergoing BMT, and enteral nutrition through a feeding tube is preferred over TPN in the absence of severe mucositis. 25 In the present study, severe gastrointestinal toxicities and sinusitis were the main problems that contraindicated placement of tube feeding among the allogenic and autologous BMT patients. However, this group of patients who experienced such problems was receiving the only alternative to parenteral nutrition for support.
Several research groups have advocated the use of percutaneous endoscopic gastrostomy (PEG) for cancer patients, especially when nutritional therapy is required for a prolonged period. [25] [26] [27] Although this method has not been tested in BMT patients, it may be useful and feasible if used early, before lesions occur in the oral mucosa and gastrointestinal tract thereby preventing tube placement in situations of aplasia with severe thrombocytopenia. Even though all the procedures for tube placement were followed, in accordance with the indications and contraindications, it was observed that more than 60% of the patients underwent tube placement after infusion of bone marrow cells, i.e. when the blood cell count was already very low and the lesions in the gastrointestinal mucosa were starting to emerge. Delay in indication of nutritional support may hamper the use of tube feeding, and predispose towards increased risk of complications. Therefore, early indication of tube feeding could benefit a greater number of patients, thereby reducing the need for TPN, or at least reducing its length of use.
On the other hand, some groups of experts are resistant to using tube feeding in BMT patients, believing that the procedure has a high risk due to gastrointestinal toxicities and the low platelet and leukocyte counts that occur in these individuals. 4 Although usually considered to be a harmless procedure, blind placement of tube feeding may result in serious and even lethal complications. Given the widespread use of tube feeding in patients of all ages, even a small percentage of such problems may affect a significant number of people. 16 In this study, tube feeding was used without major complications, thereby contributing 51%
of TEE and demonstrating that the method was feasible in this population of cancer patients.
Enteral nutrition has been extensively recommended for adults and infants during cancer treatment. In this study, no differences in the reasons that contraindicate use or placement of tube feeding could be perceived between the types of BMT. However, with the exception of the refusal of patients or relatives to undergo this procedure, the main reasons that did not allow the use of tube feeding in both groups were severe gastrointestinal problems and the presence of sinusitis.
Patients undergoing BMT procedures are at increased risk of organ toxicity due to the aggressiveness of the therapeutic implants.
Gastrointestinal toxicities such as mucositis, nausea and vomiting are expected in patients undergoing BMT. 19 Several patients in this Because of the frequency of gastrointestinal toxicities in these patients, especially mucositis and enteritis, changes in the formulation of enteral feeding may be necessary in order to facilitate tolerance. In many cases, diets that are easier to digest and absorb are used. In this study, we observed that a semi-elemental diet was required at some time during the treatment in 81% of the autologous and 60% of the allogenic BMT patients.
Bone marrow toxicity, which leads the patient to bone marrow failure, is one of the biggest challenges faced by the team, because of the high risk of death in this group. There is evidence that allogenic transplantation contributes more to the risk factors for overall complications, mainly due to increased inflammatory response, with higher synthesis of pro-inflammatory cytokines during this phase. This condition seems to be further aggravated in allogenic unrelated transplantation, which was not included in this study because, at that time, the institution had not yet performed this type of BMT. 8, 35 Although no significant differences between autologous and allogenic cases were observed in this study, regarding the presence of minor complications from use of tube feeding, the patients who underwent allogenic BMT had a greater percentage of these complications, which were mainly gastrointestinal and infectious diseases, thus corroborating the data in the literature.
The results also showed that patients who underwent allogenic BMT had more difficulty in achieving energy supply with nutritional support. This could be correlated with the greater number and severity of complications in this group, thereby also indicating higher nutritional risk and a worse clinical outcome. Hence, there is a need for controlled trials to assess the applicability and benefits of nutritional support, in particular regarding the use of tube feeding and PEG, and especially through investigating early indication.
CONCLUSION
Enteral nutrition is a feasible procedure in patients undergoing BMT and should be encouraged. The main difficulty faced by BMT patients in using tube feeding is gastrointestinal toxicities.
It is important to conduct controlled clinical trials to assess the applicability and benefits of nutritional support, and in particular the applicability of tube feeding and PEG, with investigations on early indication.
